微小核糖核酸化合物及調節MIR-21活性的方法

• 收藏
• 分享

专利权人:

Sanofi

发明人:

BHAT, Balkrishen

申请号：

HK18102629.5

公开号：

HK1243130A

申请日:

2018.02.23

申请国别(地区):

HK

年份:

2018

代理人:

摘要：

Described herein are compositions and methods for the inhibition of miR-21 activity. The compositions have certain nucleoside modification patterns that yield potent inhibitors of miR-21 activity. The compositions may be used to inhibit miR-21, and also to treat diseases associated with abnormal expression of miR-21, such as fibrosis and cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/